chartexchange

NERV
Minerva Neurosciences, Inc
stockNASDAQ

Market OpenNov 19, 2026 3:17:06 PM EST
2.13USD-2.294%(-0.05)119,823
2.1100Bid2.1400Ask0.0300Spread
Loading…
Loading…
106.15M
Healthcare
Biotechnology
CEO
Remy Luthringer
HQ
Burlington, MA, USA
Previous Close
$2.18
Beta
1.74
52-Week High
$8.80 2026-03-16
52-Week Low
$1.96 2026-10-30
SMA 50
$2.88
SMA 200
$4.78
Avg. Vol 10D
170,089
Avg. Vol 30D
184,653
Avg. Vol 90D
184,274
Relative Vol
0.65
39.33M
1.6900%
1,768
Jun 21, 2022 · 1-for-8 (reverse)
NERV Profile

minerva neurosciences, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. its lead product candidate is roluperidone, which is in phase iii clinical trial, a compound for the treatment of schizophrenia. the company is also developing seltorexant that has completed phase iib clinical trial for treating insomnia and major depressive disorders; and min-301, which is in pre-clinical trial, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of parkinson's disease. minerva neurosciences, inc. has a license agreement with mitsubishi tanabe pharma corporation for the development and commercialization of the roluperidone worldwide, excluding asia; and co-development and license agreement with janssen pharmaceutica, n.v. for the development of seltorexant. the company was formerly known as cyrenaic pharmaceuticals, inc. and changed its

NERV Performance
PeriodPriceDateChangeBeta
1W2.382026-11-12-10.50%2.004
1M2.322026-10-19-8.19%2.336
3M4.792026-08-19-55.53%2.302
6M4.362026-05-19-51.15%1.918
1Y4.302025-11-19-50.47%1.742
2Y2.102024-11-19+1.43%—
5Y8.962021-11-19-76.23%0.286
NERV Stock Summary

Minerva Neurosciences, Inc (NASDAQ:NERV) stock price today is $2.13, and today's volume is 119,805. NERV is down 2.294% today. The 30 day average volume is 184,653. NERV market cap is $106.15M with 49.84M shares outstanding.